LAUNCH's Therapeutics Portfolio

MitoChem Therapeutics develops treatments to address the effects of mitochondrial dysfunction in neurodegenerative, aging, and disease.

NXI Therapeutics develops next-gen immunosuppressive drugs for autoimmune diseases and organ transplantation.

Engimmune Therapeutics is a platform and product development company engineering next-generation T cell receptor therapies.

Zylö Therapeutics offers an innovative sustained-release drug-delivery system.

IDBiologics is a human monoclonal antibodies for the prevention, treatment, and cure of infectious diseases.

Cancentus is a cancer treatment company that provides AI-based disease discovery solutions.

Smileyscope solves pediatric problems using VR keeping kids calm and still during needles, allowing clinicians to do their job safely.

Holobiome is an owner and operator of a therapeutic company intended to treat diseases of the enteric and central nervous systems.

Elastrin Therapeutics is a biotech company developing novel therapies to reverse cardiovascular disease.

Stromal Therapeutics is the biotechnological spin-off from the Kantonsspital St.Gallen.

Greenlight Health is a digital health platform that helps researchers and clinicians create validated real-world programs.

FokusLabs creates cutting-edge smart wearables that leverage vibration technology to increase focus and productivity.

Aukera Therapeutics is a biotech company that develops novel therapeutics for patients suffering from mTOR protein related diseases.

Intact Therapeutics is a makers of smart gels for local drug delivery for gastrointestinal diseases.